| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Gyre Therapeutics, Inc. (GYRE) has 6 insiders with recent SEC Form 4 filings, including 7 buys and 5 sells. GYRE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.57M | $15.72M | - | |
| 10% | 2.14M | $13.14M | - | |
| CFO | 95.1K | $582.7K | - | |
| Dir | 52.0K | $318.8K | - | |
| CFO | 50.0K | $306.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2024 | Usman Nassim67 | Director | Sale+OE | 20,000 | $14.13 | $282,577.00 | -66.4% | +2.7% | -32.6% | |
| Apr 1, 2024 | Usman Nassim67 | Director | Sale+OE | 20,000 | $16.15 | $323,000.00 | -92.4% | -24.0% | -59.6% | |
| Mar 15, 2024 | Usman Nassim67 | Director | Sale+OE | 20,000 | $17.26 | $345,200.00 | -92.4% | -34.1% | -27.7% | |
| Aug 9, 2022 | Usman Nassim67 | President &CEO | Buy | 3,250 | $0.47 | $1,527.50 | +15.3% | +13.8% | +14.8% | |
| Aug 9, 2022 | Miller Seline E. | SVP Finance; Interim CFO &Pao | Buy | 3,250 | $0.47 | $1,527.50 | +100.0% | +13.8% | +14.8% | |
| Aug 9, 2022 | Blouse Grant E.51 | Chief Scientific Officer | Buy | 3,250 | $0.47 | $1,527.50 | +52.7% | +13.8% | +14.8% | |
| Feb 9, 2022 | Usman Nassim67 | President &CEO | Buy | 3,250 | $0.46 | $1,495.00 | +18.0% | -33.9% | +192.0% | |
| Feb 9, 2022 | Miller Seline E. | SVP Finance; Interim CFO &Pao | Buy | 3,250 | $0.46 | $1,495.00 | New | -33.9% | +192.0% | |
| Feb 9, 2022 | Blouse Grant E.51 | Chief Scientific Officer | Buy | 3,250 | $0.46 | $1,495.00 | +111.4% | -33.9% | +192.0% | |
| Aug 9, 2021 | Usman Nassim67 | President &CEO | Buy | 867 | $3.62 | $3,138.54 | +5.0% | -26.5% | -57.0% |